Request Information about Mom2Mom or educational materials

Request Information

If you are a patient and your question is about a medical condition, then you should consult with a healthcare professional or, in the case of an emergency, call 911 immediately.

Please contact us for additional information.

Yes, I would like to receive information about HemophiliaMoms.com, Hemophilia, and CSL Behring products, programs, and services.

All fields marked with an asterisk (*) are required.
*Salutation:
*Suffix:
*First Name:
*Last Name:
*I am a:	Consumer Healthcare Professional
This is my:	Home Address Work Address
*Address 1:
Address 2:
*City :
*State :
*ZIP Code :
Telephone Number
*E-mail Address :
*Confirm E-mail Address :
I have questions about the information I am requesting and would like a CSL Behring representative to contact me by: Phone
E-mail

*My key area of interest is (check all that apply):
Hemophilia A Hemophilia B von Willebrand disease

I would like to receive Mom2Mom E-News-e-mail reminders to let me know when a new mom’s story or other updates are featured on HemophiliaMoms.com.

I would like the following educational materials sent to me:

Raising a Child With Hemophilia: A Practical Guide for Parents
Dental Care for Infants, Toddlers, and Preschoolers With Bleeding Disorders
Dental Care for Children With Bleeding Disorders: Ages 5 to 10
Dental Care for Adolescents With Bleeding Disorders: Ages 11 to 18
Dental Care for Adults With Bleeding Disorders
A Family Guide to Hemophilia B
Teach Your Child About Hemophilia
Tell Them the Facts! (ages 11 to 16)
Joshua: The Knight of the Red Snake (ages 3 to 7)
They Will Probably Ask You... “What is Hemophilia?”(ages 7 to 11)
Must You Always Be a Boy?

*Type in the verification word and select “Submit”


Prior to submitting your information, please review our Privacy Policy
I would like to unsubscribe from this e-mail program.

Important Safety Information for Helixate^®FS

Helixate^® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A.

The most frequently reported adverse events were local injection-site reactions, dizziness, and rash.

Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Helixate^® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Helixate^® FS.

Please see the full prescribing information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.